LGALS3BP and liver disorder: Chronic HCV infection is associated with elevated plasma levels of systemic markers of immune activation such as sCD14, sCD163, IL-18, Mac-2BP, ATX, and IP-10, more so in patients with advanced liver disease [19–22].